Clinical Trials Browser

Prostatic Neoplasms × Rosiglitazone × Genitourinary × Clear all

NCT00182052 2013-05-23

Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms